|
Convergent Validity of the EQ-5D and PGWB: Spearman correlations with condition-specific measures and BMI |
|||||||||||
| DSC-R Scales |
|||||||||||
| ADS |
Total Score |
Fatigue |
Cognitive |
Pain |
Sensory |
Cardiology |
Ophthalmology |
Hypoglycemia |
Hyperglycemia |
BMI1 |
|
|
|
|||||||||||
| EQ-5D |
|||||||||||
| Index Score |
-.52*** |
-.64*** |
-.61*** |
-.46*** |
-.51*** |
-.53*** |
-.56*** |
-.22* |
-.44*** |
-.46*** |
-.27** |
| VAS |
-.49*** |
-.53*** |
-.50*** |
-.43*** |
-.39*** |
-.41*** |
-.45*** |
-.19* |
-.33*** |
-.37*** |
-.38*** |
| PGWB |
|||||||||||
| Global Score |
-.61*** |
-.71*** |
-.76*** |
-.61*** |
-.46*** |
-.48*** |
-.54*** |
-.24** |
-.56*** |
-.45*** |
-.24** |
| Anxiety |
-.48*** |
-.58*** |
-.62*** |
-.50*** |
-.38*** |
-.37*** |
-.43*** |
-.19* |
-.52*** |
-.37*** |
-.15 |
| Depressed Mood |
-.55*** |
-.57*** |
-.65*** |
-.52*** |
-.37*** |
-.33*** |
-.48*** |
-.15 |
-.48*** |
-.34*** |
-.16 |
| Positive Well-Being |
-.61*** |
-.60*** |
-.65*** |
-.56*** |
-.39*** |
-.40*** |
-.45*** |
-.19* |
-.52*** |
-.34*** |
-.19* |
| Self-Control |
-.54*** |
-.61*** |
-.61*** |
-.60*** |
-.40*** |
-.42*** |
-.47*** |
-.25** |
-.49*** |
-.38*** |
-.20* |
| General Health |
-.52*** |
-.68*** |
-.66*** |
-.47*** |
-.50*** |
-.58*** |
-.50*** |
-.32*** |
-.44*** |
-.45*** |
-.28** |
| Vitality |
-.58*** |
-.67*** |
-.81*** |
-.59*** |
-.38*** |
-.45*** |
-.49*** |
-.19* |
-.50*** |
-.43*** |
-.28*** |
|
BMI = Body Mass Index; ADS = Appraisal of Diabetes Scale; DSC-R = Diabetes Symptom Checklist – Revised; PGWB = Psychological General Well-Being Index; VAS = Visual Analog Scale; 1Body Mass Index = (weight in pounds/[height in inches]2) × 703; *p < 0.05; **p < 0.01; ***p < 0.001 | |||||||||||
Matza et al. Health and Quality of Life Outcomes 2007 5:47 doi:10.1186/1477-7525-5-47 |
|||||||||||